These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 2580481)

  • 1. Mechanism of action and selective toxicity of ascamycin, a nucleoside antibiotic.
    Osada H; Isono K
    Antimicrob Agents Chemother; 1985 Feb; 27(2):230-3. PubMed ID: 2580481
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Occurrence of an ascamycin dealanylating enzyme, Xc-aminopeptidase, in mammalian cell membranes and susceptibility to ascamycin.
    Osada H; Isono K
    J Antibiot (Tokyo); 1986 Feb; 39(2):286-93. PubMed ID: 3514563
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Structure and biological activity of ascamycin, a new nucleoside antibiotic.
    Isono K; Uramoto M; Osada H; Ubukata M; Kusakabe H; Koyama T; Miyata N; Sethi SK; McCloskey JA
    Nucleic Acids Symp Ser; 1984; (15):65-7. PubMed ID: 6395097
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Purification and characterization of ascamycin-hydrolysing aminopeptidase from Xanthomonas citri.
    Osada H; Isono K
    Biochem J; 1986 Jan; 233(2):459-63. PubMed ID: 3754135
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ascamycin and dealanylascamycin, nucleoside antibiotics from Streptomyces sp.
    Isono K; Uramoto M; Kusakabe H; Miyata N; Koyama T; Ubukata M; Sethi SK; McCloskey JA
    J Antibiot (Tokyo); 1984 Jun; 37(6):670-2. PubMed ID: 6547710
    [No Abstract]   [Full Text] [Related]  

  • 6. Characterization of biosynthetic genes of ascamycin/dealanylascamycin featuring a 5'-O-sulfonamide moiety in Streptomyces sp. JCM9888.
    Zhao C; Qi J; Tao W; He L; Xu W; Chan J; Deng Z
    PLoS One; 2014; 9(12):e114722. PubMed ID: 25479601
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Isolation and characterization of the gene encoding an aminopeptidase involved in the selective toxicity of ascamycin toward Xanthomonas campestris pv. citri.
    Sudo T; Shinohara K; Dohmae N; Takio K; Usami R; Horikoshi K; Osada H
    Biochem J; 1996 Oct; 319 ( Pt 1)(Pt 1):99-102. PubMed ID: 8870654
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of protein synthesis by amicetin, a nucleoside antibiotic.
    Bloch A; Coutsogeorgopoulos C
    Biochemistry; 1966 Oct; 5(10):3345-51. PubMed ID: 4961660
    [No Abstract]   [Full Text] [Related]  

  • 9. Antimicrobial properties and mode of action of the pyrrothine holomycin.
    Oliva B; O'Neill A; Wilson JM; O'Hanlon PJ; Chopra I
    Antimicrob Agents Chemother; 2001 Feb; 45(2):532-9. PubMed ID: 11158751
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Bactericidal action of lomefloxacin a new pyridonecarboxylic acid derivative].
    Koikeda S; Okabe H; Shibata H; Hase T; Nakanishi N; Okezaki E; Kato H; Masamune Y
    Jpn J Antibiot; 1989 Jan; 42(1):193-9. PubMed ID: 2468799
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Effect of heliomycin on protein and nucleic acid synthesis in Escherichia coli].
    Korolev PN; Bulgakova VG; Polin AN; Melikhova EI; Silaev AB
    Mikrobiologiia; 1975; 44(3):400-3. PubMed ID: 1099407
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of bacterial protein synthesis by elongation-factor-Tu-binding antibiotics MDL 62,879 and efrotomycin.
    Landini P; Bandera M; Goldstein BP; Ripamonti F; Soffientini A; Islam K; Denaro M
    Biochem J; 1992 May; 283 ( Pt 3)(Pt 3):649-52. PubMed ID: 1590753
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sublethal concentrations of pleurocidin-derived antimicrobial peptides inhibit macromolecular synthesis in Escherichia coli.
    Patrzykat A; Friedrich CL; Zhang L; Mendoza V; Hancock RE
    Antimicrob Agents Chemother; 2002 Mar; 46(3):605-14. PubMed ID: 11850238
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Study of the mechanism of action of minocycline and of certain other tetracycline group compounds].
    Beliavskaia IV; Kukhanova MK; Sazykin IUu ; Navashin SM
    Antibiotiki; 1976 Mar; 21(3):242-5. PubMed ID: 776077
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Preliminary characterization of an antibiotic produced by Xanthomonas albilineans which inhibits DNA synthesis in Escherichia coli.
    Birch RG; Patil SS
    J Gen Microbiol; 1985 May; 131(5):1069-75. PubMed ID: 2410547
    [TBL] [Abstract][Full Text] [Related]  

  • 16. LL-49F233alpha, a novel antibiotic produced by an unknown fungus: biological and mechanistic activities.
    Singh MP; Zaccardi J; Greenstein M
    J Antibiot (Tokyo); 1998 Dec; 51(12):1109-12. PubMed ID: 10048571
    [No Abstract]   [Full Text] [Related]  

  • 17. Antibacterial nitroacridine, Nitroakridin 3582: effects on bacterial growth and macromolecular biosynthesis in vivo.
    Wolfe AD; Cook TM; Hahn FE
    J Bacteriol; 1971 Oct; 108(1):320-7. PubMed ID: 4941562
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lactoferricin B inhibits bacterial macromolecular synthesis in Escherichia coli and Bacillus subtilis.
    Ulvatne H; Samuelsen Ø; Haukland HH; Krämer M; Vorland LH
    FEMS Microbiol Lett; 2004 Aug; 237(2):377-84. PubMed ID: 15321686
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mechanism of action of DuP 721: inhibition of an early event during initiation of protein synthesis.
    Eustice DC; Feldman PA; Zajac I; Slee AM
    Antimicrob Agents Chemother; 1988 Aug; 32(8):1218-22. PubMed ID: 2461163
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Streptothricin F, an inhibitor of protein synthesis with miscoding activity.
    Haupt I; Hübener R; Thrum H
    J Antibiot (Tokyo); 1978 Nov; 31(11):1137-42. PubMed ID: 363671
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.